Associate Professor of Internal Medicine
Assistant Division Chief for Inpatient Endocrine Service
Section Head, Internal Medicine
Program Director of Fellowship, Endocrinology
Department of Internal Medicine, MEND
1150 W Med Ctr Dr
Ann Arbor, MI 48109
[email protected]
1150 W Med Ctr Dr
Ann Arbor, MI 48109
Available to mentor
Tobias Else
Associate Professor
-
Metabolism, Endocrinology and Diabetes FellowshipUniversity of Michigan, Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes (MEND), 2014
-
Internal Medicine ResidencyUniversity of Michigan, Department of Internal Medicine, 2010
-
Adrenal development, tumorigenesis and telomere pathophysiologyUniversity of Michigan, MEND, 2008
-
MDUniversity of Hamburg, Martinistrasse 52, 2000
-
Center MemberCaswell Diabetes Institute
-
Center MemberRogel Cancer Center
-
Aykut A, Else T, Demirci H. Can J Ophthalmol, 2024 Dec; 59 (6): e862 - e865.Journal ArticleBelzutifan as the first-line treatment for a challenging von Hippel-Lindau-related retinal hemangioblastoma: successful treatment of a case and review of the literature.
DOI:10.1016/j.jcjo.2024.05.025 PMID: 39043253 -
Shabet C, Kattapuram M, Burton A, Thoeny R, Nielsen H, Accardo ML, Smith EH, Koeppe E, Else T, Cha KB. Fam Cancer, 2024 Nov; 23 (4): 543 - 550.Journal ArticleA retrospective cohort study of genetic referral and diagnosis of Birt-Hogg-Dubé Syndrome in patients with Trichodiscoma and Fibrofolliculoma skin lesions.
DOI:10.1007/s10689-024-00402-2 PMID: 38822938 -
Wiley HE, Srinivasan R, Maranchie JK, Chhablani J, Iversen ABB, Kruse A, Jonasch E, Gombos DS, Else T, Demirci H, Maughan BL, Hartnett ME, Coleman HR, Fu W, Perini RF, Liu Y, Linehan WM, Chew EY, LITESPARK-004 Investigator Group - Ocular VHL . Ophthalmology, 2024 Nov; 131 (11): 1324 - 1332.Journal ArticleOral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study.
DOI:10.1016/j.ophtha.2024.05.024 PMID: 38849055 -
Del Rivero J, Else T, Hallanger-Johnson J, Kiseljak-Vassiliades K, Raj N, Reidy-Lagunes D, Srinivas S, Gilbert J, Vaidya A, Aboujaoude E, Bancos I, Tito Fojo A. Oncologist, 2024 Sep 6; 29 (9): 747 - 760.Journal ArticleA review of mitotane in the management of adrenocortical cancer.
DOI:10.1093/oncolo/oyae084 PMID: 39037424 -
Kuo ME, Smith EH, Plotzke J, Chan M, Else T, Cha KB. JAAD Case Rep, 2024 Sep; 51: 66 - 68.Journal ArticleIncidental melanoma and thyroid cancer lead to diagnosis of Lynch syndrome and endometrial cancer: A case report.
DOI:10.1016/j.jdcr.2024.06.023 PMID: 39188332 -
Beuschlein F, Else T, Bancos I, Hahner S, Hamidi O, van Hulsteijn L, Husebye ES, Karavitaki N, Prete A, Vaidya A, Yedinak C, Dekkers OM. J Clin Endocrinol Metab, 2024 Jun 17; 109 (7): 1657 - 1683.Journal ArticleEuropean Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency.
DOI:10.1210/clinem/dgae250 PMID: 38724043 -
Flynn A, Pattison AD, Balachander S, Boehm E, Bowen B, Dwight T, Rosello F, Hofmann O, Martelotto L, Zethoven M, Kirschner LS, Else T, Fishbein L, Gill AJ, Tischler AS, Giordano T, Prodanov T, Noble JR, Reddel RR, Trainer AH, Ghayee HK, Bourdeau I, Elston M, Ishak D, Ngeow Yuen Yie J, Hicks RJ, Crona J, Åkerström T, Stålberg P, Dahia P, Grimmond S, Clifton-Bligh R, Pacak K, Tothill RW. 2024 Jun 25;PreprintMulti-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.
DOI:10.21203/rs.3.rs-4410500/v1 PMID: 38978571 -
Else T, Wong KK, Frey KA, Brooks AF, Viglianti BL, Raffel DM. J Endocr Soc, 2024 Apr 6; 8 (6): bvae049Journal Article3-[18F]Fluoro-para-hydroxyphenethylguanidine (3-[18F]pHPG) PET-A Novel Imaging Modality for Paraganglioma.
DOI:10.1210/jendso/bvae049 PMID: 38617812